PT Prodia Widyahusada Tbk (ISX:PRDA) 3-Year ROIIC % : -34.91% (As of Dec. 2025)


ISX:PRDA PT Prodia Widyahusada Tbk ISX:PRDA
69 GF Score
Price Rp2,430.00
GF Value Rp3,131.21
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is PT Prodia Widyahusada Tbk 3-Year ROIIC %?

PT Prodia Widyahusada Tbk ISX:PRDA -2.80% 69 3-Year ROIIC % is -34.91 as of Dec. 2025. GuruFocus rates ISX:PRDA with a GF Score™ of 69/100 and a GF Value™ of Rp3,131.21 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 203 Medical Diagnostics & Research companies, PT Prodia Widyahusada Tbk ranks worse than 77.34% on this metric.

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. PT Prodia Widyahusada Tbk's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was -34.91%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for PT Prodia Widyahusada Tbk's 3-Year ROIIC % or its related term are showing as below:

ISX:PRDA's 3-Year ROIIC % is ranked worse than
77.34% of 203 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.22 vs ISX:PRDA: -34.91

PT Prodia Widyahusada Tbk  (ISX:PRDA) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


PT Prodia Widyahusada Tbk 3-Year ROIIC % Related Terms


PT Prodia Widyahusada Tbk 3-Year ROIIC % Historical Data

* Premium members only.

The historical data trend for PT Prodia Widyahusada Tbk's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Prodia Widyahusada Tbk 3-Year ROIIC % Chart

PT Prodia Widyahusada Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
3-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 353.64 40.92 -1.30 -40.45 -34.91

PT Prodia Widyahusada Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
3-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -34.91 0.00

ISX:PRDA vs TMO, DHR, IDXX: 3-Year ROIIC % Comparison

For the Diagnostics & Research subindustry, PT Prodia Widyahusada Tbk's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Prodia Widyahusada Tbk 3-Year ROIIC % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, PT Prodia Widyahusada Tbk's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where PT Prodia Widyahusada Tbk's 3-Year ROIIC % falls into.


ISX:PRDA
69GF Score
PT Prodia Widyahusada Tbk ISX:PRDA
3-Year ROIIC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Prodia Widyahusada Tbk 3-Year ROIIC % Calculation

PT Prodia Widyahusada Tbk's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( 177577.309 (Dec. 2025) - 352593.9765 (Dec. 2022) )/( 1859686 (Dec. 2025) - 1358287 (Dec. 2022) )
=-175016.6675/501399
=-34.91%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.

Frequently Asked Questions Learn more about 3-Year ROIIC % →
What does a 3-Year ROIIC % of -34.91 mean?
PT Prodia Widyahusada Tbk (ISX:PRDA) has a 3-Year ROIIC % of -34.91 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on PT Prodia Widyahusada Tbk and its competitors. According to the industry distribution chart, PT Prodia Widyahusada Tbk ranks #157 out of 203 companies in the Medical Diagnostics & Research industry, placing it in the top 77.3%.
Is PT Prodia Widyahusada Tbk's 3-Year ROIIC % too high?
PT Prodia Widyahusada Tbk's current 3-Year ROIIC % is -34.91. Based on the distribution chart, PT Prodia Widyahusada Tbk ranks #157 out of 203 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, PT Prodia Widyahusada Tbk has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Prodia Widyahusada Tbk's 3-Year ROIIC % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, PT Prodia Widyahusada Tbk ranks #157 out of 203 companies for 3-Year ROIIC %. This places PT Prodia Widyahusada Tbk in the lower half of its industry. The industry median 3-Year ROIIC % is 0.22. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Diagnostics & Research company?
The median 3-Year ROIIC % among Medical Diagnostics & Research companies is 0.22, based on 203 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on PT Prodia Widyahusada Tbk and its competitors. For the Medical Diagnostics & Research industry, the median 3-Year ROIIC % is 0.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Prodia Widyahusada Tbk's current 3-Year ROIIC % is -34.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Prodia Widyahusada Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Prodia Widyahusada Tbk (ISX:PRDA) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp3,131.21, compared to a current price of Rp2,430.00 — trading 22.4% below its estimated fair value. The current 3-Year ROIIC % is -34.91. PT Prodia Widyahusada Tbk's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For PT Prodia Widyahusada Tbk (ISX:PRDA), the current 3-Year ROIIC % is -34.91 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Prodia Widyahusada Tbk (ISX:PRDA) Overvalued in 2026?

Based on GuruFocus' analysis, PT Prodia Widyahusada Tbk stock appears to be undervalued. The current stock price of Rp2,430.00 is trading 22.4% below its estimated GF Value™ of Rp3,131.21. GuruFocus considers PT Prodia Widyahusada Tbk to be Modestly Undervalued.

Key valuation signals for ISX:PRDA:

  • 3-Year ROIIC %: -34.91
  • GF Value™: Rp3,131.21 vs. price of Rp2,430.00 (22.4% below fair value)
  • GF Score™: 69/100 with 2 warning signs

No single metric tells the full story. See the ISX:PRDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Prodia Widyahusada Tbk Business Description

Address Jl. Kramat Raya No.150, Prodia Tower, Pusat, Jakarta, IDN, 10430
PT Prodia Widyahusada Tbk provides health care testing services. The company provides analytic and diagnostic services for the medical professionals. It is engaged in health laboratories by conducting business activities such as setting up clinics, health laboratories, management of hospitals, and health checkup services. Its operating segments are Central: Jakarta; Sumatera: Sumatera, Kepulauan Riau; Greater Jakarta: Jakarta, Bogor, Depok, Tangerang, Bekasi, Lampung, Pangkal Pinang; West Java; Central Java; East Java, Bali, Nusa Tenggara; Kalimantan Sulampua: Kalimantan, Sulawesi, Ambon, Papua.
69GF Score

Get the complete analysis for ISX:PRDA

3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp2,430.00
Price
Rp3,131.21
GF Value